MX9307608A - Inhibidores de la liberacion de la citocina y antagonistas de la il-1,procedimiento para su preparacion y composiciones farmaceuticas que loscontienen. - Google Patents
Inhibidores de la liberacion de la citocina y antagonistas de la il-1,procedimiento para su preparacion y composiciones farmaceuticas que loscontienen.Info
- Publication number
- MX9307608A MX9307608A MX9307608A MX9307608A MX9307608A MX 9307608 A MX9307608 A MX 9307608A MX 9307608 A MX9307608 A MX 9307608A MX 9307608 A MX9307608 A MX 9307608A MX 9307608 A MX9307608 A MX 9307608A
- Authority
- MX
- Mexico
- Prior art keywords
- cytokine release
- antagonists
- procedure
- contain
- preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/145—Fungal isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/02—Oxygen as only ring hetero atoms
- C12P17/08—Oxygen as only ring hetero atoms containing a hetero ring of at least seven ring members, e.g. zearalenone, macrolide aglycons
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/645—Fungi ; Processes using fungi
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Genetics & Genomics (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- Botany (AREA)
- Vascular Medicine (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Dermatology (AREA)
- Mycology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929225396A GB9225396D0 (en) | 1992-12-04 | 1992-12-04 | Improvements in or relating to organic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9307608A true MX9307608A (es) | 1995-01-31 |
Family
ID=10726140
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9307608A MX9307608A (es) | 1992-12-04 | 1993-12-02 | Inhibidores de la liberacion de la citocina y antagonistas de la il-1,procedimiento para su preparacion y composiciones farmaceuticas que loscontienen. |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP0606044A1 (OSRAM) |
| JP (1) | JPH06228122A (OSRAM) |
| KR (1) | KR940014377A (OSRAM) |
| CN (1) | CN1095417A (OSRAM) |
| AU (1) | AU5211293A (OSRAM) |
| CA (1) | CA2110553A1 (OSRAM) |
| CZ (1) | CZ261493A3 (OSRAM) |
| FI (1) | FI935409L (OSRAM) |
| GB (1) | GB9225396D0 (OSRAM) |
| HU (1) | HUT65910A (OSRAM) |
| IL (1) | IL107838A0 (OSRAM) |
| MX (1) | MX9307608A (OSRAM) |
| NO (1) | NO934372L (OSRAM) |
| NZ (1) | NZ250344A (OSRAM) |
| PL (1) | PL301281A1 (OSRAM) |
| SK (1) | SK135493A3 (OSRAM) |
| TW (1) | TW258736B (OSRAM) |
| ZA (1) | ZA939088B (OSRAM) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4228328C2 (de) * | 1992-08-26 | 1999-02-11 | Agie Sa | Maschine und Verfahren zum funkenerosiven Drahtschneiden mit einer im Querschnitt verformten Drahtelektrode |
| US5795910A (en) * | 1994-10-28 | 1998-08-18 | Cor Therapeutics, Inc. | Method and compositions for inhibiting protein kinases |
| US5731343A (en) * | 1995-02-24 | 1998-03-24 | The Scripps Research Institute | Method of use of radicicol for treatment of immunopathological disorders |
| EP0823429B1 (en) * | 1995-04-26 | 2000-07-12 | Kyowa Hakko Kogyo Co., Ltd. | Radicicol derivatives |
| EP1140069A1 (en) * | 1998-12-24 | 2001-10-10 | Novation Pharmaceuticals Inc. | COMPOUNDS WHICH AFFECT mRNA STABILITY AND USES THEREFOR |
| WO2002016369A2 (en) | 2000-08-25 | 2002-02-28 | Sloan-Kettering Institute For Cancer Research | Novel macrocycles and uses thereof |
| JP2004292314A (ja) * | 2000-12-14 | 2004-10-21 | Chugai Pharmaceut Co Ltd | ケラチノサイト増殖抑制剤 |
| JP2004292315A (ja) * | 2000-12-14 | 2004-10-21 | Chugai Pharmaceut Co Ltd | Tak1阻害剤 |
| GB0112522D0 (en) * | 2001-05-23 | 2001-07-11 | Ici Plc | Catalytic process |
| US7915306B2 (en) * | 2002-03-08 | 2011-03-29 | Eisai Co., Ltd. | Macrocyclic compounds useful as pharmaceuticals |
| CA2478065C (en) | 2002-03-08 | 2013-01-08 | Eisai Co. Ltd. | Macrocyclic compounds useful as pharmaceuticals |
| CN1652743A (zh) * | 2002-04-17 | 2005-08-10 | 大正制药株式会社 | 毛发生长补剂 |
| US20060079494A1 (en) * | 2004-09-27 | 2006-04-13 | Santi Daniel V | Specific kinase inhibitors |
| US7601852B2 (en) | 2006-05-11 | 2009-10-13 | Kosan Biosciences Incorporated | Macrocyclic kinase inhibitors |
| CN105748465A (zh) | 2007-07-25 | 2016-07-13 | 卫材R&D管理株式会社 | 用于治疗癌症的多激酶抑制剂 |
| CA2704048A1 (en) | 2007-10-29 | 2009-05-07 | Eisai R & D Management Co., Ltd. | Methods for prognosing the ability of a zearalenone analog compound to treat cancer |
| CN101889005B (zh) | 2007-12-07 | 2015-06-03 | 卫材R&D管理株式会社 | 玉米赤霉烯酮大环内酯类似物合成过程中的中间物 |
| BRPI0920246A2 (pt) | 2008-10-17 | 2017-06-27 | Winconsin Alumni Res Foundation | método de preparação de alfa-beta peptídios biologicamente ativos. |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3196019A (en) * | 1964-04-06 | 1965-07-20 | Purdue Research Foundation | Anabolic and estrogenic compound and process of making |
-
1992
- 1992-12-04 GB GB929225396A patent/GB9225396D0/en active Pending
-
1993
- 1993-11-29 EP EP93810835A patent/EP0606044A1/en not_active Withdrawn
- 1993-12-02 CA CA002110553A patent/CA2110553A1/en not_active Abandoned
- 1993-12-02 IL IL10783893A patent/IL107838A0/xx unknown
- 1993-12-02 NO NO934372A patent/NO934372L/no unknown
- 1993-12-02 FI FI935409A patent/FI935409L/fi not_active Application Discontinuation
- 1993-12-02 PL PL93301281A patent/PL301281A1/xx unknown
- 1993-12-02 AU AU52112/93A patent/AU5211293A/en not_active Abandoned
- 1993-12-02 SK SK1354-93A patent/SK135493A3/sk unknown
- 1993-12-02 CZ CZ932614A patent/CZ261493A3/cs unknown
- 1993-12-02 NZ NZ250344A patent/NZ250344A/en unknown
- 1993-12-02 MX MX9307608A patent/MX9307608A/es unknown
- 1993-12-03 ZA ZA939088A patent/ZA939088B/xx unknown
- 1993-12-03 JP JP5303866A patent/JPH06228122A/ja active Pending
- 1993-12-03 HU HU9303444A patent/HUT65910A/hu unknown
- 1993-12-03 KR KR1019930026567A patent/KR940014377A/ko not_active Withdrawn
- 1993-12-03 CN CN93120777A patent/CN1095417A/zh active Pending
- 1993-12-06 TW TW082110279A patent/TW258736B/zh active
Also Published As
| Publication number | Publication date |
|---|---|
| HUT65910A (en) | 1994-07-28 |
| CZ261493A3 (en) | 1994-07-13 |
| IL107838A0 (en) | 1994-04-12 |
| TW258736B (OSRAM) | 1995-10-01 |
| NZ250344A (en) | 1995-10-26 |
| FI935409A0 (fi) | 1993-12-02 |
| ZA939088B (en) | 1995-06-05 |
| PL301281A1 (en) | 1994-06-13 |
| FI935409A7 (fi) | 1994-06-05 |
| GB9225396D0 (en) | 1993-01-27 |
| NO934372L (no) | 1994-06-06 |
| EP0606044A1 (en) | 1994-07-13 |
| NO934372D0 (no) | 1993-12-02 |
| JPH06228122A (ja) | 1994-08-16 |
| AU5211293A (en) | 1994-06-16 |
| HU9303444D0 (en) | 1994-04-28 |
| CN1095417A (zh) | 1994-11-23 |
| SK135493A3 (en) | 1994-08-10 |
| KR940014377A (ko) | 1994-07-18 |
| CA2110553A1 (en) | 1994-06-05 |
| FI935409L (fi) | 1994-06-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9307608A (es) | Inhibidores de la liberacion de la citocina y antagonistas de la il-1,procedimiento para su preparacion y composiciones farmaceuticas que loscontienen. | |
| AR063555A1 (es) | Derivados de androstano, su uso en la fabricacion de medicamentos, composiciones farmaceuticas que los comprenden y procesos para prepararlos | |
| MX9202166A (es) | Derivados de amidino fenil alanina, procedimiento para su preparacion su empleo y agentes que los con tienen en calidad de anticoagulantes. | |
| FR2681862B1 (fr) | Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent. | |
| PT100514A (pt) | 3-aminoquinuclidinas substituidas e composicoes farmaceuticas que qs contem | |
| SE8300736D0 (sv) | Novel pharmacologically active compounds | |
| AR045900A1 (es) | Compuesto glucocorticoesteroide, composiciones farmaceuticas que los contienen y su uso para el tratamiento de trastornos inflamatorios y/o alergicos. | |
| AR023823A1 (es) | Compuestos derivados de piperazina utiles como antagonistas ccr5, composiciones farmaceuticas que los comprenden, y el uso de los mismos para la preparacion de medicamentos. | |
| GT200100014A (es) | Compuestos de amida y composiciones farmaceuticas para inhibir proteinquinasas, y su modo de empleo. | |
| ES2194468T3 (es) | Uso de derivados del bisindol indigoide para la fabricacion de un medicamento para inhibir quinasas dependientes de ciclinas. | |
| AR029383A1 (es) | Moleculas pequenas, los intermediarios para su sintesis, las composiciones farmaceuticas que las contienen y su uso para preparar un medicamento destinado al tratamiento o la profilaxis de enfermedades inflamatorias o mediadas por celulas inmunes | |
| HUP0203378A2 (hu) | Gyógyszerészeti vegyületek és ezeket tartalmazó gyógyszerkészítmények | |
| EA200200520A1 (ru) | Производные гетероциклоалкилсульфонилпиразола в качестве противовоспалительных/анальгетических агентов | |
| ES2128519T3 (es) | Nuevas pirido-tiadiazinas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen. | |
| IT1251166B (it) | Derivati di geneserina,loro preparazione e composizioni farmaceutiche che li contengono | |
| ES2115904T3 (es) | Derivados amino ramificados del tiazol, sus procedimientos de preparacion y las composiciones farmaceuticas que los contienen. | |
| EA200100516A1 (ru) | Производные 3,3-биарилпиперидина и 2,2-биарилморфолина | |
| DK1032556T3 (da) | Farmaceutisk aktive forbindelser og anvendelsesfremgangsmåder | |
| ES2176321T3 (es) | Derivados tetrasustituidos del imidazol, su procedimiento de preparacion, su aplicacion como medicamentos y las composiciones farmaceuticas que los contienen. | |
| ES2111175T3 (es) | Piperazinas 1,4-disustituidas utiles en el tratamiento del asma y de inflamaciones de las vias respiratorias. | |
| EP0604354A3 (en) | Antidepressant and anti-Parkinson's disease compounds. | |
| ATE161017T1 (de) | Inhibitoren gegen die aggregation von blutplättchen | |
| ID28365A (id) | Turunan produk alami yang baru | |
| MX9305510A (es) | Compuestos para el tratamiento o profilaxis de desordenes gastrointestinales, cardiovasculares y del sistema nervioso central, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
| ES2083394T3 (es) | Nuevas arilsulfonamidas, medicamentos que contienen estos compuestos y procedimiento para su preparacion. |